Navigation Links
Menstrual Bleeding Treatment Safer Than Thought
Date:1/23/2009

Ablation technique is a less invasive alternative to hysterectomy, researchers note

FRIDAY, Jan. 23 (HealthDay News) -- Far fewer women than previously thought need additional surgery to stop excessive or prolonged menstrual bleeding after undergoing an alternative to hysterectomy called global endometrial ablation (GEA), a new study finds.

GEA, a relatively new procedure, has been regarded as being just as effective as hysterectomies while being less invasive with slightly lower complication rates and costs. During the surgery, heat, cold, microwave or radiofrequency energy is used to destroy only the uterine lining while keeping the uterus intact. Scar tissue then forms and monthly menstrual flow and its pain typically decrease.

The Mayo Clinic study, published in the January issue of Obstetrics and Gynecology, found that about 16 percent -- nearly half of past estimates -- of women required a hysterectomy to treat excessive bleeding in the first five years following an ablation.

"We've known for the past five to six years that global endometrial ablation devices are very effective," Mayo Clinic gynecologic surgeon Abimbola Famuyide, one of the study's authors, said in a news release issued by the facility. "But some physicians have observed that up to 30 percent of patients may require additional treatment five years and beyond after undergoing ablation."

More susceptible to a lack of permanent symptom relief, according to the the team, were GEA patients younger than 45 who had a tubal ligation to prevent pregnancy or had debilitating menstrual pain prior to the procedure.

Excessive or prolonged menstrual bleeding affects an estimated one in five women at some time in their lives, often during the onset of menopause.

The low failure rate, the researchers suggested, might also mean that the study sample contained many patients properly counseled to have realistic expectations
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding
2. Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Womens Menstrual Blood
3. Complementary medicines can help mild depression and premenstrual syndrome
4. Delayed Sleep Pattern Tied to Irregular Menstrual Cycles
5. Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression
6. Differing attitudes found between women and doctors concerning menstrual suppression
7. MRI Scans Reveal Post-Heart Attack Bleeding
8. Bleeding hearts revealed with new scan
9. CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
10. Steroid After Tonsillectomy Raises Bleeding Risk
11. Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Menstrual Bleeding Treatment Safer Than Thought
Menstrual Bleeding Treatment Safer Than Thought
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Say Cheese With Milk 47498 1Say Cheese With Milk 47498 2Say Cheese With Milk 47498 3Say Cheese With Milk 47498 4Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3